Biggest News Aggregation in the World
📰 Scientific Presentations News

Page 2 - Scientific Presentations News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Scientific Presentations. Real-time updates on events, politics, business and more.

SCYNEXIS Reports Second Quarter 2023 Financial Results and Provides Corporate Update - SCYNEXIS (NASDAQ:SCYX)

SCYNEXIS reported the closing of an exclusive license agreement with GSK for BREXAFEMME® (Ibrexafungerp Tablets). SCYNEXIS received an upfront payment of $90 million upon deal close.SCYNEXIS announced the
David Angulo Irina Koffler Hansoh Pharma Triterpenoid Antifungals Preclinical Development Program Hansoh Pharmaceutical Group Company

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023 - Aligos Therapeutics (NASDAQ:ALGS)

-Presentations include a late breaking poster from an ongoing Phase 1b study of ALG-000184 demonstrating multi-log reductions in HBsAg, DNA, and RNA levels in subjects dosed for up to 36 weeks- -Data collectively
Corey Davis Lawrence Blatt Tongfei Wu Jinlin Hou Veronica Eames Yannick Debing

Aligos Therapeutics Presents Data from its Liver Disease Programs at the European Association for the Study of the Liver (EASL) Congress 2023

-Presentations include a late breaking poster from an ongoing Phase 1b study of ALG-000184 demonstrating multi-log reductions in HBsAg, DNA, and RNA levels in subjects dosed for up to 36 weeks- -Data collectively highlight company’s progress advanc...
Tongfei Wu Lawrence Blatt Alina Jucov Kusum Gupta Jin Hong Veronica Eames

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Escient Pharmaceuticals Announces Presentation of Data Demonstrating Efficacy of EP262 in Inhibition of Mast Cell Degranulation in Multiple Species at the European Academy of Allergy and Clinical Immunology

Data shows that EP262 attenuates mast cell degranulation in multiple species including human MRGPRX2 knock-in mice, Beagle dogs and human ex vivo skin explants Results support the initiation
San Diego United States Mecklenburg Vorpommern Stefan Klotter Aaron Mishel Escient Pharmaceuticals Inc

4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting

Interim data to be presented in an oral presentation by Dr. Jennifer L. Taylor-Cousar, MD, MSCS at the 2023 ECFS Annual Meeting in Vienna, Austria on Thursday, June 8, 2023 at 5:00 p.m. CET Company to... | May 24, 2023
United States Jenniferl Taylor Cousar Julian Pei Katherine Smith Exchange Commission Corporate Communications

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science